Page last updated: 2024-12-05

triethylsilane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Triethylsilane is an organosilicon compound with the formula SiH(CH2CH3)3. It is a colorless liquid that is used as a reducing agent in organic synthesis. Triethylsilane is synthesized by the reaction of silicon tetrachloride with triethylaluminum. It is a powerful reducing agent that can reduce a wide range of functional groups, including ketones, aldehydes, and esters. Triethylsilane is also used as a hydrosilylating agent in the synthesis of organosilicon compounds. Triethylsilane is studied because of its wide range of applications in organic chemistry. It is a versatile reagent that can be used to synthesize a variety of compounds. Triethylsilane is also a relatively safe and easy-to-handle reagent. The compound is relatively unreactive in the absence of a catalyst. Triethylsilane is important because it is a versatile reagent that can be used to synthesize a variety of compounds. It is a valuable tool for organic chemists and is used in a variety of industrial processes. Triethylsilane is also a relatively safe and easy-to-handle reagent.'

Cross-References

ID SourceID
PubMed CID12052
CHEBI ID188370
MeSH IDM0501225

Synonyms (29)

Synonym
einecs 210-535-3
nsc 93579
0f9429873l ,
unii-0f9429873l
c6h16si
triethylsilane ,
silane, triethyl-
617-86-7
nsc93579
nsc-93579
triethylsilicon hydride
CHEBI:188370
triethylsilan
triethylsilylhydride
triethylhydrosilane
triethyl silane
S12352
triethylsilane [mi]
et3sih
triethysilane
triethyl silyl hydride
hsiet3
trietylsilane
siet3h
triethylsilyl hydride
triethyl-silane
BCP28314
triethylsilane,triethylsilyl hydride
Q659235
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
reducing agentThe element or compound in a reduction-oxidation (redox) reaction that donates an electron to another species.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organosilicon compoundAn organosilicon compound is a compound containing at least one carbon-silicon bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (47.62)29.6817
2010's10 (47.62)24.3611
2020's1 (4.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.52 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index74.48 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]